Drug intelligence / Profile preview

Iodirin-F

Development stage: Unknown
Lead developer: MTI Medical
Modality: Small Molecules
Administration: Oral

Overview

Iodirin-F is a combination nutraceutical supplement developed by MTI Medical, containing potassium iodide and L-methyl folate (levomefolate). It is formulated for oral administration to provide nutritional support during conception and pregnancy. The product is specifically indicated for the prevention of neural tube defects and to support healthy fetal development. Potassium iodide serves as a source of iodine, which is essential for maternal thyroid function and fetal brain development, while L-methyl folate is the biologically active form of folic acid required for DNA synthesis, cellular division, and the prevention of congenital malformations.

Brand names: Iodirin-F
Other names: potassium iodide + L-methyl folatepotassium iodide + levomefolate

Beyond the preview

Go deeper on Iodirin-F.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Iodirin-F.

Explore the full profile